![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF |
| Autoimmune Disorders |
|
Free Subscription
2 Am J Kidney Dis |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Autoimmune Disorders is free of charge.
Complement in Kidney Disease: Core Curriculum 2026.
Am J Kidney Dis. 2026;88:781-796.
PubMed
Abstract available
Outcomes Following Kidney Failure From IgA Nephropathy Compared to Diabetic
Kidney Disease and Other Glomerular Diseases.
Am J Kidney Dis. 2026 Oct 22:S0272-6386(26)01182.
PubMed
Abstract available
Efgartigimod-responsive autoimmune peripheral neuropathy with concurrent anti-GM2
IgG and anti-contactin-1 IgG antibodies: a rare case report.
BMC Neurol. 2026;26:657.
PubMed
Abstract available
Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T
cells resist expansion.
Brain. 2026 Oct 21:awag308. doi: 10.1093.
PubMed
Insulin Dosing Is Associated With Cardiac Sympathetic Predominance Independent of
Glycemic Profiles in Type 1 Diabetes Under Free-Living Conditions.
Diabetes. 2026 Sep 14:db260456. doi: 10.2337/db26-0456.
PubMed
Abstract available
What Proportion of Antibody-Negative Type 1 Diabetes Cases Have a Nonautoimmune
Etiology? A Genetics-Based Estimate.
Diabetes. 2026 Aug 24:db251110. doi: 10.2337/db25-1110.
PubMed
Abstract available
Baseline Serum Metabolites as Predictors of Teplizumab Response in Individuals
With Type 1 Diabetes.
Diabetes. 2026 Aug 18:db260158. doi: 10.2337/db26-0158.
PubMed
Abstract available
Successful Inhaled Sargramostim Therapy for Autoimmune Pulmonary Alveolar
Proteinosis in a Patient with an Intellectual Disability: A Caregiver-Assisted
Approach.
Intern Med. 2026 Oct 22. doi: 10.2169/internalmedicine.8088.
PubMed
Abstract available
Letter to the Editor from Latupeirissa et al: "Maternal TSH-receptor antibodies
predict fetal/neonatal hyperthyroidism in pregnancies with a history of Graves
disease".
J Clin Endocrinol Metab. 2026 Oct 19:dgag427. doi: 10.1210.
PubMed
Renal steatosis in the tubulointerstitial compartment in primary
glomerulopathies: biopsy evidence and correlation with disease severity.
J Nephrol. 2026;39:1470-1478.
PubMed
Abstract available
Prediction of short-term and long-term responses to cladribine in
relapsing-remitting multiple sclerosis: a Danish nationwide real-world study.
J Neurol. 2026;273:676.
PubMed
Abstract available
DELPHI expert consensus-derived factors influencing the early use of monoclonal
high-efficacy therapies in treatment-naive patients with relapsing-remitting
multiple sclerosis.
J Neurol. 2026;273:679.
PubMed
Abstract available
Investigating the Impact of Juvenile Idiopathic Arthritis on Health, Costs, and
Quality of Life in Australia: The IMPACT Study.
J Pediatr. 2026;298:115246.
PubMed
Abstract available
Long-term efficacy and safety for the complement factor B inhibitor iptacopan in
IgA nephropathy.
Kidney Int. 2026 Oct 22:S0085-2538(26)00826-4. doi: 10.1016/j.kint.2026.
PubMed
Abstract available
Characterization of IgA, IgA immune complexes and complement depositions in IgA
nephropathy using laser microdissection and mass spectrometry.
Kidney Int. 2026 Oct 23:S0085-2538(26)00850-1. doi: 10.1016/j.kint.2026.
PubMed
Abstract available
Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and
REMODEL-2): two randomised, phase 3 trials.
Lancet. 2026 Oct 23:S0140-6736(26)02058-1. doi: 10.1016/S0140-6736(26)02058.
PubMed
Abstract available
The clinical relevance of multiple sclerosis genetics: from susceptibility to
disease severity and progression.
Lancet Neurol. 2026 Oct 23:S1474-4422(26)00356.
PubMed
Abstract available
Increased autoimmune disease burden before multiple sclerosis and neuromyelitis
optica spectrum disorder diagnosis: A nationwide Korean cohort study.
Mult Scler. 2026 Oct 17:13524585261494379. doi: 10.1177/13524585261494379.
PubMed
Abstract available
Who declines neurocognitive testing? A cross-sectional study in people with
multiple sclerosis.
Mult Scler. 2026 Oct 17:13524585261491122. doi: 10.1177/13524585261491122.
PubMed
Abstract available
Lymphocytosis as a biomarker for natalizumab treatment response in multiple
sclerosis: The link with anti-drug antibodies.
Mult Scler. 2026 Oct 17:13524585261495351. doi: 10.1177/13524585261495351.
PubMed
Abstract available
Ofatumumab and enteroviral encephalitis: a severe infectious complication as a
class effect with anti-CD20 therapies.
Mult Scler. 2026;32:1339-1342.
PubMed
Abstract available
Interim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy.
N Engl J Med. 2026 Oct 23. doi: 10.1056/NEJMoa2608682.
PubMed
Abstract available
Sibeprenlimab in IgA Nephropathy - Final Phase 3 Trial Analysis.
N Engl J Med. 2026 Oct 22. doi: 10.1056/NEJMoa2609127.
PubMed
Abstract available
Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial.
N Engl J Med. 2026 Oct 23. doi: 10.1056/NEJMoa2607544.
PubMed
Abstract available
Atacicept in IgA Nephropathy - Phase 3 Trial Final Efficacy Analysis.
N Engl J Med. 2026 Oct 22. doi: 10.1056/NEJMoa2610103.
PubMed
Abstract available
A Multidisciplinary Neuro-Lupus Program for the Evaluation and Management of
Patients With SLE and Cognitive Concerns.
Neurol Clin Pract. 2026;16:e200680.
PubMed
Abstract available
Differential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4
+ NMOSD: The Role of Disease Activity in MOGAD.
Neurology. 2026;107:e218673.
PubMed
Abstract available
Gray Matter Damage and Long-Term Disability, Cognitive Outcome, and Survival in
Patients With Multiple Sclerosis.
Neurology. 2026;107:e218641.
PubMed
Reader Response: Screening for Congenital Myasthenic Syndromes in Adults With
Seronegative Myasthenia Gravis Using Next-Generation Sequencing.
Neurology. 2026;107:e214850.
PubMed
Editors' Note: Screening for Congenital Myasthenic Syndromes in Adults With
Seronegative Myasthenia Gravis Using Next-Generation Sequencing.
Neurology. 2026;107:e218759.
PubMed
Author Response: Screening for Congenital Myasthenic Syndromes in Adults With
Seronegative Myasthenia Gravis Using Next-Generation Sequencing.
Neurology. 2026;107:e214896.
PubMed
Harnessing autoantibodies to target pathogenic plasma cells.
Proc Natl Acad Sci U S A. 2026;123:e2631232123.
PubMed
Smartphone-Based Deep Learning Exophthalmometry in Thyroid Eye Disease: A
Multicenter, Multiethnic Validation Study.
Thyroid. 2026 Oct 7:10507256261495636. doi: 10.1177/10507256261495636.
PubMed
Abstract available
Thank you for your interest in scientific medicine.